0000899243-17-025203.txt : 20171101 0000899243-17-025203.hdr.sgml : 20171101 20171101214042 ACCESSION NUMBER: 0000899243-17-025203 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20171101 FILED AS OF DATE: 20171101 DATE AS OF CHANGE: 20171101 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Margolin Alexey L CENTRAL INDEX KEY: 0001350080 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38268 FILM NUMBER: 171170542 MAIL ADDRESS: STREET 1: C/O ALTUS PHARMACEUTICALS INC. STREET 2: 125 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Allena Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001624658 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 452729920 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE NEWTON EXECUTIVE PARK STREET 2: SUITE 202 CITY: NEWTON STATE: MA ZIP: 02462 BUSINESS PHONE: 617-467-4577 MAIL ADDRESS: STREET 1: ONE NEWTON EXECUTIVE PARK STREET 2: SUITE 202 CITY: NEWTON STATE: MA ZIP: 02462 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2017-11-01 0 0001624658 Allena Pharmaceuticals, Inc. ALNA 0001350080 Margolin Alexey L C/O ALLENA PHARMACEUTICALS, INC. ONE NEWTON EXECUTIVE PARK, SUITE 202 NEWTON MA 02459 1 1 0 0 Chief Executive Officer Common Stock 808752 D Stock Option (Right to Buy) 0.75 2024-03-05 Common Stock 20834 D Stock Option (Right to Buy) 0.75 2024-05-15 Common Stock 9998 D Stock Option (Right to Buy) 1.17 2024-12-16 Common Stock 215620 D Stock Option (Right to Buy) 1.59 2026-03-10 Common Stock 131768 D 25% of the shares vested on March 5, 2015 and the remaining shares vest in 36 equal monthly installments thereafter. 25% of the shares vested on May 15, 2015 and the remaining shares vest in 36 equal monthly installments thereafter. 25% of the shares vested on December 16, 2015 and the remaining shares vest in 36 equal monthly installments thereafter. 25% of the shares vested on December 8, 2016 and the remaining shares vest in 36 equal monthly installments thereafter. Exhibit 24 - Power of Attorney /s/ Kevin Brennan, attorney-in-fact 2017-11-01 EX-24 2 attachment1.htm EX-24 DOCUMENT

                               Power of Attorney

     Know all by these presents that the undersigned hereby constitutes and
appoints Alexey Margolin, Michael H. Bison, Daniel A. Lang and Edward Wholihan,
and with full power of substitution, as the undersigned's true and lawful
attorney-in-fact to:

       (1) execute for and on behalf of the undersigned, in the undersigned's
       capacity as a director of Aliena Pharmaceuticals, Inc., a Delaware
       corporation (the Company), Forms 3, 4, and 5 in accordance with Section
       l6(a) of the Securities Exchange Act of l934, as amended, and the rules
       thereunder;

       (2) do and perform any and all acts for and on behalf of the undersigned
       which may be necessary or desirable to complete and execute any such Form
       3, 4 , or 5 , complete and execute any amendment or amendments thereto,
       and timely file such form with the SEC and any stock exchange or similar
       authority; and

       (3) take any other action of any type whatsoever in connection with the
       foregoing which, in the opinion of such attorney-in-fact, may be of
       benefit to, in the best interest of, or legally required by, the
       undersigned, it being understood that the documents executed by such
       attorney-in-fact on behalf of the undersigned pursuant to this Power of
       Attorney shall be in such form and shall contain such terms and
       conditions as such attorney-in-fact may approve in such attorney-in-
       fact's discretion.

     The undersigned hereby grants to each such attorney-in-fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary, or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might or
could do if personally present, with full power of substitution or revocation,
hereby ratifying and confirming all that such attorney-in-fact, or such
attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be
done by virtue of this power of attorney and the rights and powers herein
granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in
serving in such capacity at the request of the undersigned , is not assuming,
nor is the Company assuming, any of the undersigned's responsibilities to comply
with Section 16 of the Securities Exchange Act of l934, as amended.

     This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4, and 5 with respect to the
undersigned's holdings of and transactions in securities issued by the Company,
unless earlier revoked by the undersigned in a signed writing delivered to the
foregoing attorneys-in-fact.

     IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 31 day of October, 2017.


/s/ Alexey Margolin
--------------------------
Name: Alexey Margolin, Ph.D.